+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Structure-function relationships of multidrug resistance P-glycoprotein

Structure-function relationships of multidrug resistance P-glycoprotein

Journal of Medicinal Chemistry 47(10): 2523-2533

The direct structure-function relationships of P-glycoprotein (P-gp) are presently unknown. In this paper two P-gp models are described: a homology model based on the Escherichia coli MsbA lipid transporter and a model based on the cross-linking results of Loo and Clarke. The pharmacophore pattern for the H-site (Hoechst 33342) is derived and binding sites on the transmembrane domains TM5 and TM11 are identified. Binding sites of rhodamines are also proposed on TM6 and TM12 in accordance with the published data. Location of the binding sites is opposite in both models, suggesting that TMs undergo rotation exposing the substrate bound from the membrane to the pore. It has been concluded that the models derived represent two different functional states of P-gp corresponding to nucleotide-free and nucleotide-bound P-gp. A qualitative correspondence to the P-gp crystallographic structure at 20 A resolution is found. A hypothesis is proposed about rearrangement of TMs upon state transition.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 012592238

Download citation: RISBibTeXText

PMID: 15115395

DOI: 10.1021/jm031009p

Related references

Structure and function of the multidrug resistance P-glycoprotein. Toxicology 178(1): 19-20, 2002

Modulation of multidrug resistance by cephalosporin antibiotics structure activity relationships with human p glycoprotein. Proceedings of the American Association for Cancer Research Annual Meeting 30: 567, 1989

Flavonoid dimers as bivalent modulators for p-glycoprotein-based multidrug resistance: structure-activity relationships. Chemmedchem 4(4): 594-614, 2009

Reversal of multidrug resistance by derivatives of acrivastin: A study of structure-activity relationships of P-glycoprotein inhibitors in vitro and in vivo. Oncology Reports 4(6): 1353-1360, 1997

Modulatory ability and structure relationships of taxane reversal agents against P-glycoprotein -, Multidrug Resistance Protein -, and Breast Cancer Resistance Protein -mediated Mitoxantrone transport. Proceedings of the American Association for Cancer Research Annual Meeting 43: 954, 2002

Structure-activity relationships studies in a series of N,N-bis(alkanol)amine aryl esters as P-glycoprotein (Pgp) dependent multidrug resistance (MDR) inhibitors. Journal of Medicinal Chemistry 53(4): 1755-1762, 2010

Jatrophane Diterpenoids as Modulators of P-Glycoprotein-Dependent Multidrug Resistance (MDR): Advances of Structure-Activity Relationships and Discovery of Promising MDR Reversal Agents. Journal of Medicinal Chemistry 59(13): 6353-6369, 2016

Biological evaluation, structure-activity relationships, and three-dimensional quantitative structure-activity relationship studies of dihydro-beta-agarofuran sesquiterpenes as modulators of P-glycoprotein-dependent multidrug resistance. Journal of Medicinal Chemistry 50(20): 4808-4817, 2007

H1, a novel derivative of tetrandrine reverse P-glycoprotein-mediated multidrug resistance by inhibiting transport function and expression of P-glycoprotein. Cancer ChemoTherapy and Pharmacology 67(5): 1017-1025, 2011

P-glycoprotein-mediated resistance to chemotherapy in cancer cells: using recombinant cytosolic domains to establish structure-function relationships. Brazilian Journal of Medical and Biological Research 32(8): 925-939, 1999

Structure of the multidrug resistance P-glycoprotein. Seminars in Cancer Biology 8(3): 135-142, 1997

Analysis of the tangled relationships between P-glycoprotein-mediated multidrug resistance and the lipid phase of the cell membrane. European Journal of Biochemistry 267(2): 277-294, 2000

Research developments on non-multidrug resistance function of P-glycoprotein. Sheng Li Ke Xue Jin Zhan 43(1): 62-65, 2012

Minimal residual disease in acute myeloid leukemia correlates with P-glycoprotein function but not with multidrug resistance protein function at diagnosis. Leukemia 17(3): 663, 2003